This thesis focuses on the treatment of peritoneal metastases of gastric and colorectal cancer, specifically using cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). A large part of this thesis is based on retrospective analysis of patients treated with CRS + HIPEC in the St. Antonius hospital, Nieuwegein, and Catherina Hospital, Eindhoven. By combining the patients’ databases of both hospitals, we were offered a large unique set of colorectal cancer patients treated with CRS + HIPEC. This made it possible to establish statistically significant conclusions regarding specific subgroups of patients with peritoneal carcinomatosis of colorectal cancer. Part 1 is concentrated on the early treatment of pe...
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis...
Abstract: Peritoneal carcinomatosis (PC) was previously considered an incurable disease with a poor ...
The peritoneum is a common site of dissemination for colorrectal cancer, with a poorer prognosis tha...
BACKGROUND AND STUDY AIM: Over the last 20 years, cytoreductive surgery (CRS) combined with hyperthe...
Cytoreductive surgery (CRS) associated with hyperthermic intra-peritoneal chemotherapy (HIPEC) repre...
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal car...
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in intra...
The incidence of peritoneal carcinomatosis of colorectal cancer amounts to 5%-15% for synchronous me...
The peritoneal cavity is a common site of metastatic spread from colorectal cancer (CRC). Patients w...
Purpose. This nationwide study evaluated results of cytoreductive surgery (CRS) combined with hypert...
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis...
Background: Peritoneal surface malignancies (PSMs) are a heterogenous group of primary and metastati...
Introduction: Intraperitoneal hyperthermic chemoperfusion has been proposed for treatment of perito...
Cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have gained increas...
Experience with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in...
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis...
Abstract: Peritoneal carcinomatosis (PC) was previously considered an incurable disease with a poor ...
The peritoneum is a common site of dissemination for colorrectal cancer, with a poorer prognosis tha...
BACKGROUND AND STUDY AIM: Over the last 20 years, cytoreductive surgery (CRS) combined with hyperthe...
Cytoreductive surgery (CRS) associated with hyperthermic intra-peritoneal chemotherapy (HIPEC) repre...
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal car...
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in intra...
The incidence of peritoneal carcinomatosis of colorectal cancer amounts to 5%-15% for synchronous me...
The peritoneal cavity is a common site of metastatic spread from colorectal cancer (CRC). Patients w...
Purpose. This nationwide study evaluated results of cytoreductive surgery (CRS) combined with hypert...
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis...
Background: Peritoneal surface malignancies (PSMs) are a heterogenous group of primary and metastati...
Introduction: Intraperitoneal hyperthermic chemoperfusion has been proposed for treatment of perito...
Cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have gained increas...
Experience with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in...
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis...
Abstract: Peritoneal carcinomatosis (PC) was previously considered an incurable disease with a poor ...
The peritoneum is a common site of dissemination for colorrectal cancer, with a poorer prognosis tha...